Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib is an effective treatment for severe alopecia areata.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

Microneedles could make it easier and less painful to deliver more types of drugs through the skin.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Continuous use of finasteride and minoxidil is effective for treating androgenetic alopecia.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Managing stress and nerve activity can help treat segmental vitiligo and white hair.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Cryotherapy may help hair regrowth in alopecia areata with possibly lower relapse rates than steroids.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

IL-10 may worsen alopecia areata instead of helping it.

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

Activating Tgr5 may help treat hair loss and bone loss.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.